Almeida, P. R. J., Periard, A. M., Tana, F. L., Avila, R. E., Milhorato, L. B., Alcantara, K. M. M., . . . Teixeira, M. M. (2024). Effects of a pro‐resolving drug in COVID‐19: Preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients. British Journal of Pharmacology, 181(23), 4750. https://doi.org/10.1111/bph.17322
Chicago Style (17th ed.) CitationAlmeida, Pedro R. J., et al. "Effects of a Pro‐resolving Drug in COVID‐19: Preclinical Studies to a Randomized, Placebo‐controlled, Phase Ib/IIa Trial in Hospitalized Patients." British Journal of Pharmacology 181, no. 23 (2024): 4750. https://doi.org/10.1111/bph.17322.
MLA (9th ed.) CitationAlmeida, Pedro R. J., et al. "Effects of a Pro‐resolving Drug in COVID‐19: Preclinical Studies to a Randomized, Placebo‐controlled, Phase Ib/IIa Trial in Hospitalized Patients." British Journal of Pharmacology, vol. 181, no. 23, 2024, p. 4750, https://doi.org/10.1111/bph.17322.